Nasus Pharma LTD (NSRX) SEC Filings — 2025
9 SEC filings for Nasus Pharma LTD (NSRX) in 2025.
Filings
- Nasus Pharma LTD 6-K Filing — 6-K · Dec 29, 2025
- Nasus Pharma LTD 6-K Filing — 6-K · Dec 22, 2025
- Nasus Pharma Appoints New CFO — 6-K · Nov 20, 2025
- Nasus Pharma Doses First Patient in NS002 Phase 2 Study — 6-K · Nov 18, 2025
- Nasus Pharma Ltd. Updates Corporate Presentation — 6-K · Nov 3, 2025
- Nasus Pharma Extends Aptar Collaboration for Epinephrine Program — 6-K · Oct 8, 2025
- Nasus Pharma Ltd. Closes Partial Over-Allotment Option Exercise — 6-K · Sep 30, 2025
- Nasus Pharma CEO Joins Board of Directors — 6-K · Sep 5, 2025
- Nasus Pharma Closes Initial Public Offering — 6-K · Aug 14, 2025